|
RBBP9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.016500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.593630E-02 |
| Normal-vs-Stage2 |
1.737760E-01 |
| Normal-vs-Stage3 |
6.122200E-01 |
| Normal-vs-Stage4 |
1.457550E-02 |
| Stage1-vs-Stage2 |
9.156600E-01 |
| Stage1-vs-Stage3 |
4.230000E-01 |
| Stage1-vs-Stage4 |
5.743400E-01 |
| Stage2-vs-Stage3 |
4.769600E-01 |
| Stage2-vs-Stage4 |
7.836000E-01 |
| Stage3-vs-Stage4 |
3.795400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.664400E-03 |
| Normal-vs-AfricanAmerican |
3.342200E-01 |
| Normal-vs-Asian |
1.512190E-01 |
| Caucasian-vs-AfricanAmerican |
4.004200E-01 |
| Caucasian-vs-Asian |
6.186600E-01 |
| AfricanAmerican-vs-Asian |
4.965800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.81630000000355E-05 |
| Normal-vs-Female |
5.645200E-01 |
| Male-vs-Female |
4.339300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.363800E-01 |
| Normal-vs-Extreme_Weight |
3.69209999999676E-05 |
| Normal-vs-Obese |
3.582800E-01 |
| Normal-vs-Extreme_Obese |
2.226800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.737000E-01 |
| Normal_Weight-vs-Obese |
4.389800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.815000E-01 |
| Extreme_Weight-vs-Obese |
1.280170E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.960000E-01 |
| Obese-vs-Extreme_Obese |
3.962200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.389600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.738000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.800570E-04 |
| Normal-vs-Age(81-100Yrs) |
3.371400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.627000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.926100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.263500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.067800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.266500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.770600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.572600E-04 |
| Normal-VS-Type2 PRCC |
4.605600E-02 |
| Normal-VS-KIRP CIMP |
9.740000E-01 |
| Normal-VS-Unclassified PRCC |
2.302800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.494000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.831010E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.440100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.957400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.691900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.328400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.952200E-02 |
| Normal-vs-N1 |
3.222000E-01 |
| Normal-vs-N2 |
1.315810E-03 |
| N0-vs-N1 |
3.451200E-01 |
| N0-vs-N2 |
5.282000E-01 |
| N1-vs-N2 |
1.354200E-01 |
|
|
